The fourth webinar in Us TOO's series, What is Right for Me in My Prostate Cancer Treatment?, is a discussion on the topic of Imaging. Continuing advances in imaging technology and usage can mean more accurate testing and diagnosis related to prostate cancer, and can help guide patients toward the best treatment options for them. Join us as we discuss the latest on this very important topic.

Dr. Brian T. Helfand is the Chief of the Division of Urology, Ronald L. Chez Family and Richard Melman Family Endowed Chair of Prostate Cancer at NorthShore University HealthSystem, in Evanston, IL. He is Clinical Associate Professor at University of Chicago, Pritzker School of Medicine, in Chicago, IL. He holds MD and PhD degrees, and is head of clinical and research programs focused on prostate cancer. Dr. Helfand has authored more than 200 peer reviewed manuscripts. Currently, his interests are devoted towards using novel imaging techniques and biomarkers, including genetics, to help guide clinical decision making for men with newly diagnosed and advanced prostate cancer.

Brian T. Helfand MD, PhD - Chief, Division of Urology, Ronald L. Chez Family and Richard Melman Family Endowed Chair of Prostate Cancer, NorthShore University HealthSystem, Evanston, IL; Clinical Associate Professor, University of Chicago, Pritzker School of Medicine, Chicago, IL

Laurence Klotz, MD, FRCSC - Professor of Surgery, University of Toronto, Toronto, Canada; Sunnybrook Chair of Prostate Cancer Research; Member of the Us TOO Board of Directors

Register at: www.ustoo.org/mypcawebinar

Genetics and Genomics - Thursday, July 29

with Dr. Heather H. Cheng and Dr. Brittany Szymaniak

For Sponsorship Opportunities, Please Email James Hutson, Us TOO Director of Development at: jamesh@ustoo.org or call 630-795-1002.